Silexion Therapeutics(SLXN)
$1.98-0.68 (-25.56%)
SLXN
Silexion Therapeutics financials statements
$1.98
At close:-0.68 (-25.56%)
Want to see SLXN full AI Analyst Report?
Silexion Therapeutics (SLXN) Income Statement
247 Followers
Silexion Therapeutics Income Statement
Last quarter (Q3 2026), Silexion Therapeutics's total revenue was $0.00. In Q3, Silexion Therapeutics's net income was $-2.53M. See Silexion Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -11.63M | $ 12.57M | $ 4.68M | $ 3.86M | $ 943.93K | |
| Depreciation and Amortization | $ 14.00K | $ 25.00K | $ 45.00K | $ 57.00K | $ 0.00 |
| $ -11.88M | $ -16.48M | $ -5.02M | $ -3.32M | $ -755.00K | |
| $ 11.63M | $ -12.57M | $ -4.68M | $ -3.86M | $ -943.93K | |
| $ -23.54M | $ -3.94M | $ -395.00K | $ 396.00K | $ 188.72K | |
| $ -11.91M | $ -16.51M | $ -5.08M | $ -3.46M | $ -755.22K | |
| $ -11.91M | $ -16.44M | $ -4.94M | $ -3.21M | $ -755.22K | |
| Per Share Metrics | |||||
| Basic EPS | $ -2150.40 | $ -94886.88 | $ -159239.52 | $ 1256.88 | $ -1647.12 |
| Diluted EPS | $ -2150.40 | $ -94886.88 | $ -159239.52 | $ 1256.88 | $ -1647.12 |
| Weighted Average Shares Outstanding | 5.54K | 173 | 31 | 465 | 458 |
| Weighted Average Shares Outstanding (Diluted) | 5.54K | 173 | 31 | 465 | 458 |
Currency in USD
